Seb Orton

Partner

Seb Orton

Partner

Email Seb

+44 (0)20 7457 3207

London

Download VCard

Services

Sectors

Seb is a partner in the corporate team based in the London office, and co-heads the firm’s equity capital markets practice. He has extensive experience advising both private and public companies and financial institutions.

His work covers a range of corporate issues with a particular focus on IPOs, secondary fundraisings, mergers and acquisitions, including public company takeovers, and assisting listed companies on corporate governance and their continuing obligations. He has wide cross-sector experience and has led on a full range of issuer and investment bank-side transactions, from a FTSE250 Main Market IPO for a financial institution and a high-profile IPO on AIM to a variety of smaller Main Market, AIM and Aquis transactions in the retail and health and care sectors.

I am an experienced equity capital markets practitioner advising issuers, investment banks and other stakeholders. I enjoy the ever-changing nature of working in the listed and regulatory environment and am sought out for my ability to provide a commercial and responsive approach to legal issues and corporate transactions.

Seb Orton, Partner

In 2004, Seb was seconded to Investec’s Corporate Finance Group and in 2011 to Citigroup’s ECM legal team in 2011. He has strong links with a variety of investment banks across the UK. Seb joined Penningtons Manches Cooper in 2019 from the City office of a leading international firm. Prior to that, he was a partner in the London office of a US law firm. He is a member of Penningtons Manches Cooper’s North America group and has extensive experience working with US and Canadian companies both listing in London and acquiring UK public companies.

Recent work highlights

Secondary fundraising on AIM

Acting for Shore Capital on a secondary fundraising for Warpaint London plc on AIM in connection with the acquisition of Brand Architekts plc (AIM).

Debt and equity raise

Advising SkinBioTherapeutics (AIM) on a debt and equity fundraising in connection with the acquisition of Bio-Tech Solutions.

Corporate restructuring advice

Acting for Cavendish Capital Markets on a secondary fundraising for Revolution Bars Group on AIM in connection with a corporate restructuring.

Share buy back

Advising Nexteq plc (AIM) on a share buy back and a waiver from independent shareholders under rule 9 of the takeover code.

Convertible bond facility on AIM

Acting for SkinBioTherapeutics (AIM) on a £5 million convertible bond facility.

Secondary fundraising on AIM

Acting for SkinBioTherapeutics (AIM) on a placing and retail offer.

US IPO on AIM

Advising finnCap on the IPO of Fadel Partners Inc. on AIM, which valued the company at £28.8 million.

Main market IPO

Acting for Oxford Cannabinoid Technologies Holdings plc on its initial public offering on the London Stock Exchange, which valued the company at £48 million.

AIM IPO

Acting for finnCap on the IPO of Parsley Box Group on AIM, which valued the company at £83.8 million.

US IPO on AIM

Advising finnCap on the IPO of Fadel Partners Inc. on AIM, which valued the company at £28.8 million.

Main market IPO

Acting for Oxford Cannabinoid Technologies Holdings plc on its initial public offering on the London Stock Exchange, which valued the company at £48 million.

AIM IPO

Acting for finnCap on the IPO of Parsley Box Group on AIM, which valued the company at £83.8 million.

External recognition
Rankings from respected legal directories reflect the reputation our lawyers have earned across their key sectors and areas of practice.

What people are saying

A top lawyer who truly stands out. He is highly skilled, very commercial and always brings a positive, enjoyable attitude to his work. He offers short, clear, practical advice without being patronising.

Legal 500

Sebastian is very commercial, knowledgeable and responsive.

Chambers UK

Related news and insights
All insights